NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 231 filers reported holding NEVRO CORP in Q4 2020. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $210,000 | -19.2% | 1,504 | 0.0% | 0.00% | -20.0% |
| Q4 2020 | $260,000 | +23.8% | 1,504 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $210,000 | +4.0% | 1,504 | -32.3% | 0.01% | 0.0% |
| Q3 2017 | $202,000 | -83.7% | 2,220 | -86.6% | 0.01% | -85.3% |
| Q2 2017 | $1,237,000 | +5.4% | 16,623 | +2.9% | 0.03% | 0.0% |
| Q4 2016 | $1,174,000 | +6.2% | 16,155 | -17.8% | 0.03% | 0.0% |
| Q1 2016 | $1,105,000 | +6.2% | 19,642 | -12.3% | 0.03% | +6.2% |
| Q3 2015 | $1,040,000 | +30.2% | 22,402 | +50.7% | 0.03% | +45.5% |
| Q2 2015 | $799,000 | +78.7% | 14,864 | +59.1% | 0.02% | +83.3% |
| Q1 2015 | $447,000 | -31.9% | 9,342 | -44.9% | 0.01% | -36.8% |
| Q4 2014 | $656,000 | – | 16,948 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
| Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
| Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
| Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
| PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
| Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
| Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
| Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
| HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
| FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |